Company Filing History:
2 out of 3 Years Active: 2022-2024
Title: Matthew Robinson: Innovator in Therapeutic Solutions
Introduction
Matthew Robinson is a distinguished inventor based in Cambridge, GB. He has made significant contributions to the field of therapeutic innovations, holding a total of 3 patents. His work primarily focuses on developing solutions for complex medical conditions.
Latest Patents
Among his latest patents, one notable invention is related to therapeutic binding molecules. This invention pertains to binding molecules, such as antibodies, that specifically target the chemokine receptor CCR9. The implications of this invention are profound, as it addresses the treatment of CCR9-mediated diseases or conditions, including inflammatory bowel disease (IBD). Additionally, it encompasses methods for detecting CCR9 using these binding molecules.
Another significant patent by Robinson involves a therapeutic bacterial composition. This invention is aimed at utilizing bacterial compositions in cancer treatment. Specifically, these compositions can serve as a co-therapy alongside immune checkpoint therapies. Furthermore, the invention includes methods for identifying subjects who are likely to respond to therapy with immune checkpoint inhibitors by assessing the abundance of bacteria in biological samples.
Career Highlights
Matthew Robinson is currently associated with Microbiotica GmbH, where he continues to advance his research and innovations. His work is pivotal in bridging the gap between microbiology and therapeutic applications, showcasing the potential of bacteria in medical treatments.
Collaborations
Robinson collaborates with esteemed colleagues, including Trevor Lawley and Michael Romanos, who contribute to his research endeavors and enhance the impact of his inventions.
Conclusion
Matthew Robinson stands out as an innovative inventor whose work in therapeutic binding molecules and bacterial compositions is paving the way for new treatment methodologies. His contributions are vital in addressing significant health challenges, and his ongoing research promises to yield further advancements in the field.